[1]
P. Wetwittayakhlang, “Adherence to Objective Therapeutic Monitoring and Outcomes in Patients with Inflammatory Bowel Disease with Adalimumab Treatment. A Real-world Prospective Study”, JGLD, vol. 31, no. 4, pp. 403-410, Dec. 2022.